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We have shown that steroid hormones coordinately control gene transcriptional activity and splicing
decisions in a promoter-dependent manner. Our hypothesis is that a subset of hormonally recruited coregu-
lators involved in regulation of promoter transcriptional activity also directly participate in alternative RNA
splicing decisions. To gain insight into the molecular mechanisms by which transcriptional coregulators could
control splicing decisions, we focused our attention on a recently identified coactivator, CoAA. This heteroge-
neous nuclear ribonucleoprotein (hnRNP)-like protein interacts with the transcriptional coregulator TRBP, a
protein recruited to target promoters through interactions with activated nuclear receptors. Using transcrip-
tional and splicing reporter genes driven by different promoters, we observed that CoAA mediates transcrip-
tional and splicing effects in a promoter-preferential manner. We compared the activity of CoAA to the activity
of other hnRNP-related proteins that, like CoAA, contain two N-terminal RNA recognition motifs (RRMs)
followed by a C-terminal auxiliary domain and either have or have not been implicated in transcriptional
control. By swapping either CoAA RRMs or the CoAA auxiliary domain with the corresponding domains of the
proteins selected, we showed that depending on the promoter, the RRMs and the auxiliary domain of CoAA are
differentially engaged in transcription. This contributes to the promoter-preferential effects mediated by CoAA
on RNA splicing during the course of steroid hormone action.
Regulation of gene expression is a complex process occur-
ring in several steps, including transcription, splicing, transcript
5- and 3-end modification (capping and polyadenylation, re-
spectively), transcript export, and stability. It is now accepted
that these different steps are “mechanistically” coupled: tran-
scription is coupled to capping, splicing, and polyadenylation;
and splicing is coupled to capping, polyadenylation, and export
(9, 30, 32, 40, 44). An emerging view of the coupling among
gene expression machines indicates that proteins involved in
early steps in the pathway can influence subsequent down-
stream steps (9, 30, 32). Transcriptional coregulators recruited
to target gene promoters by DNA-binding transcriptional fac-
tors, including nuclear receptors, could play a major role in this
regard (2, 13, 35, 37). Among the more than 100 coregulators
identified to date that participate directly in transcriptional
regulation, a subset of these proteins are structurally or func-
tionally related to proteins involved in pre-mRNA processing
(2, 11, 13, 14, 37).
Functional principles for the “mechanical” coordination be-
tween the different steps of the gene expression process are
emerging (7, 12, 38). Most human primary transcripts contain
several exons separated by introns that are removed during the
splicing reaction. Due to the presence of multiple splice sites,
the RNA-splicing process can lead to the production of mul-
tiple mature transcripts. Alternative splicing is more a rule
than an exception since up to 60% of the human gene products
are alternatively spliced (7, 12, 15, 38, 48). This mechanism
permits diversity of translatable mRNAs, thereby increasing
the proteome diversity encoded by a limited number of genes
(7, 12, 31, 38). The “mechanical” coupling of transcription to
splicing could allow the transcriptional machinery to simulta-
neously control the amount and the nature (exon content) of
the transcript. This hypothesis is supported by reports showing
that promoter architecture influences splicing decisions (6, 17,
42). In this context, we also have shown that activated steroid
hormone receptors control gene transcription and affect splic-
ing decisions in a promoter-dependent manner (2). Our hy-
pothesis is that hormonally activated nuclear receptors recruit
a set of transcriptional coregulators which may participate in
the splicing decisions of the neonascent transcripts (2). Sup-
porting this hypothesis, we and others have shown that tran-
scriptional coregulators can indeed affect splicing decisions (2,
11, 14, 37).
To gain insight into the molecular mechanisms by which
transcriptional coregulators affect splicing decisions, we fo-
cused our attention on a recently identified protein, CoAA
(16). CoAA was identified as an interacting protein with the
transcriptional coregulator TRBP; TRBP was cloned by sev-
eral groups as an LXXLL domain-containing protein that in-
teracts with several nuclear receptors (5, 20, 23, 29, 56). CoAA
is a heterogeneous nuclear ribonucleoprotein (hnRNP)-like
protein similar in structure to a family of proteins involved in
pre-mRNA processing (16, 48, 51, 52). CoAA contains two
RNA recognition motifs (RRMs) within the N-terminal part of
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the protein. An auxiliary domain within the C-terminal part
contains the TRBP-interacting domain (TRBP-ID [see Fig. 3])
and is rich in glycine and tyrosine residues (16). CoAA en-
hances the transcriptional activity of several transcription fac-
tors, and we have reported that it affects splicing decisions for
transcripts from a minigene derived from the human CD44
gene (2, 16).
To better understand the function and activity of CoAA, we
compared this protein to two other hnRNP-related proteins.
We selected hnRNPA1 because it contains two N-terminal
RRMs followed by a glycine- and tyrosine-rich auxiliary do-
main (see Fig. 3) and has been shown to affect CD44 splicing
but is not described as being engaged in the transcription
process (34, 52). p54nrb is highly similar to the polypyrimidine
tract binding protein-associated factor and was selected for its
structural and functional similarities to CoAA (see Fig. 3).
Like CoAA, p54nrb contains two N-terminal RRMs and is
engaged both in transcription and in pre-mRNA processing (3,
28, 33, 43, 45, 55). p54nrb and CoAA have been identified in a
nuclear compartment termed paraspeckles, suggesting that
these proteins could have similar functions (10).
Transcription factors and transcriptional coregulators con-
tain domains that allow the proteins to be recruited to the
promoter through either DNA or protein interactions and an
activation domain having either enzymatic activity or allowing
the recruitment of other regulatory (or enzymatic) proteins
through protein-protein interactions to the promoter (1, 13,
35). Similarly, splicing factors can interact with their RNA
substrates via RRM domains and can presumably recruit other
proteins through their auxiliary domains (48, 51, 52, 54). Based
on these observations, we speculated that the RRMs and the
auxiliary domains of these proteins might mediate different
activities in terms of both splicing and transcription, allowing
for a functional comparison of each of these proteins by ex-
changing domains between them.
After demonstrating that TRBP is recruited to the progest-
erone-regulated mouse mammary tumor virus (MMTV) pro-
moter, we demonstrate that both CoAA-mediated transcrip-
tional and splicing effects are enhanced by TRBP, suggesting
that CoAA-mediated effects are promoter dependent. Sup-
porting this hypothesis, we observe that CoAA affects both
transcription and splicing in a promoter-preferential manner.
By swapping the RRMs and the auxiliary domains of CoAA,
p54nrb, and hnRNP A1, we demonstrate that depending on
the promoter, the RRMs and the auxiliary domain of CoAA
are differently engaged in transcription, contributing to the
promoter-preferential effects on RNA splicing mediated by
CoAA.
MATERIALS AND METHODS
Plasmids. The cytomegalovirus (CMV) immediate-early enhancer/promoter
from pCDNA3.1 (Invitrogen), the herpes simplex virus (HSV) thymidine kinase
promoter from pRL-TK (Promega), the MMTV promoter from MMTV-KCR-
LUC (Dr. S. Chua, Baylor College of Medicine), the (PRE)2-TATA, and the
(ERE)2-TATA promoters were cloned into the pGL3 basic-luciferase reporter
(Promega). The above promoters were placed upstream of the previously de-
scribed CD44 and CT/CGRP test genes (27, 49). The precise cloning steps are
available on request. The CoAA, hnRNPA1, and p54nrb cDNAs were cloned
into pcDNA3 containing a myc epitope at the 3 end (Invitrogen). The region
corresponding to either the RRMs or the auxiliary domains of the different
proteins were amplified by PCR and cloned into pcDNA3-myc. Either at the 3
end of the RRMs or at the 5 end of the auxiliary domains, an EcoRV site was
inserted, allowing domain switching among the proteins (see Fig. 3A). The
precise cloning steps are available on request. All clonings were verified by
sequencing and the expression level of the proteins was verified after transfection
and Western blot analysis using a myc antibody (data not shown).
Transfection and chromatin immunoprecipitation (ChIP). The chromatin im-
munoprecipitation (ChIP) assay was performed with a TRBP antibody using a
cell line containing a stably integrated MMTV chloramphenicol acetyltransferase
reporter gene as previously described (26). Real-time PCR was performed using
CYBR Green PCR master mix from Applied Biosystems. Transfection experi-
ments were done in triplicate using 12-well plates. A transfection master mix was
prepared for three wells. Steroid receptors at 5 ng/well were cotransfected with
300 ng of reporter genes per well (except for CMV containing reporter genes, for
which 5 ng/well supplemented with 300 ng of pBlueScript vector was used) and
300 ng of different expression vectors per well (except where indicated), using
Lipofectamine reagent (Invitrogen) as specified by the manufacturer. After 6 h
of incubation, the medium was replaced with medium containing 5% stripped
fetal bovine serum and progesterone (Pg; 108 M) or estradiol (E2; 109 M).
After 24 h of incubation at 37°C under 5% CO2, the cells were harvested using
either RLT buffer (Promega) for the luciferase assay or 1 ml of TRIzol (Invitro-
gen) for each set of triplicate wells for RNA isolation as specified by the man-
ufacturer.
DNase treatment and RT-PCR. A DNase treatment master mix containing
AMV/Tfl reaction buffer (Access RT-PCR system; Promega), MgSO4 (2.5 mM
final concentration), and RQ1 DNase (1 U; Promega) was prepared and ali-
quoted to digest plasmid DNA contamination from RNA preparations for 1 h at
37°C, this was followed by 15 min of DNase heat inactivation at 65°C. An aliquot
of this reaction mixture was used for reverse transcription-PCR (RT-PCR) using
the Access RT-PCR system. RT-PCR master mix containing radiolabeled prim-
ers at 1 M was prepared as specified by the manufacturer. The primers were
radiolabeled using [-32P]ATP (4,500 Ci/mmol) and T4 kinase (Invitrogen) as
specified by the manufacturer. The primers were as follows: sense CD44 primer,
AGACACCATGCATGGTGCACC; antisense CD44 primer, CCATAACAGC
ATCAGGAGTG; sense CT/CGRP primer, CATCGCTGTCTGCGAGGGCC;
antisense CT/CGRP (exon 4), GAGTTTAGTTGGCATTCTGG; antisense CT/
CGRP (exon5), CTGCTCAGGCTTGAAGGTCC. Radioactive RT-PCR prod-
ucts derived from CT/CGRP minigenes were fractionated on nondenaturing 5%
polyacrylamide gels. Radioactive RT-PCR products derived from CD44 mini-
genes were fractionated on denaturing 5% polyacrylamide gels. Dried gels were
exposed to autoradiographic films or placed in PhosphorImager cassettes to
allow quantification by the PhosphorImaging system (Molecular Dynamics).
DNase heat inactivation at 65°C permits destabilization of RNA secondary
structures; for the same reason, the RT step was performed at 48°C. To avoid
cross-contamination and variability, we used the Access RT-PCR system (Pro-
mega), which allows the RT and PCR steps to be performed in the same tube.
Only 20 cycles of PCR (30 s at 94°C, 45 s at 56°C, and 1 min at 68°C) were
performed (2).
RESULTS
CoAA-mediated effects on transcription and splicing are
enhanced by TRBP. While we had shown earlier that activated
steroid hormone receptors simultaneously regulate transcrip-
tion and splicing decisions in a promoter-dependent manner
(2), our hypothesis was that activated nuclear receptors recruit
a subset of coregulators participating in both transcription and
alternative splicing regulation. To test this hypothesis, we in-
vestigated the transcriptional and splicing activity of CoAA, an
hnRNP-like protein recently identified as a nuclear receptor
coactivator (16). CoAA interacts with the transcriptional co-
regulator TRBP, which, in turn, interacts with members of the
nuclear receptor family, including the progesterone receptor
(PR) (5, 16, 20, 23, 29, 56). Using a ChIP assay, we observed
that TRBP was recruited to a Pg-activated MMTV promoter
(Fig. 1A). Pg treatment enhanced PR recruitment ca. sixfold
and TRBP recruitment ca. fourfold to the targeted MMTV
promoter (Fig. 1A and data not shown). As a negative control,
and as we already have shown, the MMTV promoter was not
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precipitated in the presence of Pg by an antibody directed
against pCAF, a particular coregulator involved in histone
acetylation (26).
CoAA was shown to enhance the transcriptional activity of
several nuclear receptors (16), and, as illustrated in Fig. 1B, the
CoAA-mediated transcriptional effect on a PR-activated
MMTV-luciferase reporter gene was strongly enhanced by
TRBP. Using 300 ng of CoAA or TRBP expression vector, we
observed a transcriptional increase of ca. 4- and ca. 2.5-fold
respectively, whereas when CoAA and TRBP were expressed
together, the MMTV-luciferase activity was increased ca. 15-
fold. As reported below, the overexpression of other hnRNP-
related proteins did not always enhance the MMTV- and/or
the TRBP-activated MMTV-luciferase activity (see Fig. 2A
and 3C). Together, these results suggest that the CoAA-medi-
ated transcriptional effects on a PR-regulated MMTV pro-
moter are TRBP dependent. Supporting this hypothesis, a
natural spliced variant of CoAA, called CoAM, that lacks the
TRBP-interacting domain did not activate transcription and
did not enhance TRBP-mediated transcriptional effects (ref-
erence 16 and data not shown).
Whereas CoAA can affect splicing decisions, we previously
FIG. 1. CoAA-mediated effects on transcription and splicing are enhanced by TRBP. (A) Agarose gel-based analysis and quantitative analysis
by real-time PCR of Pg-stimulated recruitment of TRBP to a stably integrated MMTV promoter by the ChIP assay (see Materials and Methods).
(B) HeLa cells were plated on 12-well plates 24 h before transfection in a 5% stripped serum-based medium. Each condition was used in triplicate
wells. Per well, 5 ng of PR and 300 ng of MMTV-luciferase reporter gene were transfected with increasing amounts of pcDNA3-CoAA expression
vector in the absence or in the presence of pcDNA3-TRBP expression vector as indicated. The amount of transfected DNA was equilibrated using
the pcDNA3-empty expression vector. The serum-free transfection medium was replaced 6 h after transfection by a 5% stripped serum-based
medium containing Pg (108 M). After 24 h of incubation, transfected cells were harvested for the luciferase assay. The luciferase activities
obtained under the different conditions were divided by the luciferase activity obtained in the control wells transfected only with the pcDNA3-
empty expression vector (first column). The histogram represents the mean and standard deviation (SD) of three separate experiments. (C) The
CD44 minigene gives rise to three spliced variants containing either the two variable exon cassettes, v4 and v5 (inclusion), none of these exons
(skipping), or one exon inclusion product (v4). HeLa cells were transfected as described for panel B, except that the reporter gene used was
MMTV-CD44. Cells were harvested using 1 ml of TRIzol for each 12-well triplicate before RNA extraction. After DNase treatment, radiolabeled
primers were used to amplify CD44 RNA products (see Materials and Methods). Autoradiograms of the radiolabeled-PCR products obtained in
a representative experiment are shown. The histogram shows the mean (and SD, n  3) quantification of the CD44 skipping/inclusion ratio
obtained in the presence of different amounts of CoAA and/or TRBP expression vectors, divided by the control skipping/inclusion ratio obtained
in the presence of only the empty expression vector (first column). (D) The CT/CGRP minigene contains two polyadenylation sites (pA) in either
exon 4, giving rise to the CT product, or exon 6, giving rise to the CGRP product. HeLa cells were transfected as described for panel B, except
that the reporter gene used was MMTV-CT/CGRP. Autoradiograms of the radiolabeled PCR products obtained in a representative experiment
are shown. The histogram shows the mean (and SD, n  3) quantification of the CT/CGRP ratio obtained in the presence of different amounts
of CoAA and/or TRBP expression vectors, divided by the control CT/CGRP ratio obtained in the presence of only the empty expression vector
(first column).
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reported that CoAM did not do so (2). Consequently, we asked
whether CoAA-mediated effects on splicing were also TRBP
dependent. To test this possibility, we used a human CD44-
derived minigene (49) driven by the MMTV promoter (Fig.
1C). Normally, the CD44 reporter used produces a mixture of
two RNAs that contain either both or neither of the CD44
alternative exons and a minor amount of intermediary RNA
containing one of the alternative exons (Fig. 1C). Increasing
the concentration of CoAA changed the ratio of the CD44
spliced products to favor the production of RNA lacking both
alternative exons. At higher concentrations, CoAA increased
the skipping/inclusion ratio ca. fivefold. TRBP increased the
skipping/inclusion ratio ca. twofold and enhanced CoAA-me-
diated splicing effects (Fig. 1C). Transfection of both CoAA
and TRBP increased the skipping/inclusion ratio up to ca.
15-fold (Fig. 1C). In the presence of 300 ng of CoAA expres-
sion vector or in the presence of both CoAA and TRBP, the
overall production of CD44 transcripts was increased com-
pared to the control lane (Fig. 1C, first lane of the autoradio-
gram corresponding to the transfection of the empty expres-
sion vector). Although this observation suggests that the
proteins tested have transcriptional effects on the MMTV-
CD44 reporter gene, we often observed a less pronounced
transcriptional effect of these proteins compared to their tran-
scriptional effect on the MMTV-luciferase reporter gene (Fig.
1B). Since the RT-PCR assay that we used was developed to
measure the relative abundance of the CD44 transcripts and
not to measure the total amount of the CD44 products syn-
thesized, no firm conclusions can be drawn regarding the tran-
scriptional output from this minigene. It also is possible that
the discrepancy observed in the amplitude of the transcrip-
tional effect mediated by the different coregulators on the
CD44 and the luciferase reporter gene could be due to differ-
ent stability of the CD44 and the luciferase transcripts since
the luciferase cDNA is designed to produce a very stable
mRNA which directs continued synthesis of luciferase prod-
ucts even after 24 h posttransfection. Finally, the overexpres-
sion of other hnRNP-related proteins led to no or differential
effects on CD44 transcripts splicing (2) (see Fig. 2B), demon-
strating the reliability and the specificity of the assay.
We further tested the splicing effects of CoAA by using a
second splicing reporter gene derived from the human CT/
CGRP gene (27), giving rise to either the CT or to the CGRP
RNAs (Fig. 1D). This splicing reporter, like CD44, involves the
alternative recognition of a weak internal exon (the black CT
exon in Fig. 1D) characterized by a weak 3-splice site requir-
ing activation by processing enhancer sequences (27, 49). The
two systems differ in that the alternative exon in CT/CGRP is
a 3-terminal exon involving differential polyadenylation as
well as splicing. In addition, the CD44 alternative splicing
decision is regulated by exon-located regulatory sequences
whereas the CT/CGRP splicing event has an intron regulator
in addition to exon-specific sequences (27, 49). Use of these
two systems permits the examination of whether CoAA regu-
lates the splicing of any weak exon to produce more products
resulting from exon skipping. As shown in Fig. 1D, increasing
the concentration of CoAA changed the ratio of the spliced
isoforms. At higher concentrations, CoAA increased the CT/
CGRP ratio ca. fourfold (Fig. 1D). Therefore, in contrast to
the situation with CD44, CoAA stimulated the inclusion rather
than the exclusion of the weak exon, indicating that the CoAA
effect is not simply an inhibition of the splicing apparatus to
hinder the recognition of weak exons. Interestingly, two- to
threefold less CoAA expression vector was required to obtain
a maximal effect on splicing in the presence of TRBP (Fig. 1D).
The CoAA-mediated effects on splicing of the CT/CGRP
products, however, reached a plateau in the presence of TRBP,
whereas the transcription response continued in the presence
of additional CoAA (Fig. 1B and D). Although we observed a
splicing effect on the CD44 transcripts when TRBP was over-
expressed alone (Fig. 1C), this coregulator did not affect CT/
CGRP splicing in the absence of CoAA (Fig. 1D). This could
be because the CoAA/TRBP complex stimulated CT produc-
tion, which was the major product synthesized in HeLa cells in
the absence of any stimulation (Fig. 1D, first lane of the auto-
radiograph).
Our results demonstrate that both transcriptional and splic-
ing CoAA-mediated effects are enhanced by TRBP (Fig. 1B to
D), which interacts with CoAA (16) and which is recruited on
the Pg-activated MMTV promoter (Fig. 1A). The data suggest
that both transcriptional and splicing CoAA-mediated effects
are promoter dependent. To test this possibility further, we
asked if the transcriptional and splicing effects mediated by
CoAA also would be observed using other promoters including
the steroid-independent CMV and HSV promoters.
CoAA mediates promoter-preferential effects on transcrip-
tion and alternative splicing. In the luciferase assay, CoAA
enhanced the activity of both the PR-activated MMTV pro-
moter and the CMV promoter to a similar extent (Fig. 2A, left
and middle graphs). This effect was not a general effect on
either transcription or luciferase activity since CoAA had no
effect on the luciferase reporter gene activity driven by the
HSV promoter (right graph). Using the CD44 reporter gene,
we observed that CoAA altered the ratio of CD44 spliced
products when CD44 pre-mRNAs were synthesized from the
PR-activated MMTV promoter but that it had minimal effects
when CD44 pre-mRNAs were synthesized from either the
CMV or the HSV promoter (Fig. 2B). In the particular exper-
iments illustrated by the autoradiograms in Fig. 2B, CoAA
enhanced the skipping/inclusion ratio by 3.9-, 1.2-, and 1.6-fold
when the CD44 pre-mRNAs were synthesized from the
MMTV, CMV, or HSV promoters, respectively. As illustrated
by the histograms in Fig. 2B, CoAA enhanced the skipping/
inclusion ratio by an average of 3  0.9, 1.2  0.2, and 1.4 
0.3-fold, respectively, using the MMTV-, CMV-, or HSV-
CD44 reporter gene. These results suggest that an RRM-con-
taining protein can affect both transcriptional activity and splic-
ing decisions in a promoter-preferential manner. Importantly,
although splicing effects mediated by RNA-binding proteins
can show promoter preferences as already reported (6, 42),
these promoter-preferential splicing effects are not a direct
consequence of transcriptional activation. Indeed, we observed
that CoAA enhanced PR-activated MMTV- and CMV-lucif-
erase activity similarly but significantly affected the splicing of
the CD44 products only when they were synthesized from the
PR-activated MMTV promoter (Fig. 2). The absence of a
direct correlation between transcriptional activation and splic-
ing effects is also consistent with our previous finding that
different transcriptional coactivators that enhance transcrip-
tion can alter splicing decisions in an opposite manner and that
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an ability to alter transcription does not necessarily alter splic-
ing decisions (2).
To test whether the promoter preference observed using
CoAA was due to intrinsic properties of the promoter used, we
studied the effect of two other hnRNP-related proteins.
hnRNP A1, known not to alter transcription output, was cho-
sen as an RNA-splicing factor which has been reported to
specifically increase exon v5 skipping on CD44 (34). As ex-
pected, hnRNP A1 had no effect on transcription using the
luciferase reporter gene driven by either the MMTV, CMV, or
HSV promoters (Fig. 2A). In contrast, it enhanced the pro-
duction of CD44-spliced RNAs containing only exon v4, as a
result of exon v5 skipping (Fig. 2B). Using primers localized in
either exon v4 or v5, we determined that the levels of the RNA
products containing only exon v4 were specifically increased in
the presence of hnRNP A1 (data not shown). The effect of
hnRNP A1 on the v4/inclusion ratio was ca. 5-, ca. 10-, and ca.
3-fold from the MMTV-, CMV-, and HSV-CD44 minigenes,
respectively. Therefore, the inability of CoAA to significantly
alter the splicing of transcripts synthesized from the CMV or
HSV promoters does not reflect an inherent ability of these
promoters to suppress the activity of hnRNP proteins on splic-
ing.
We examined the ability of p54nrb, known as both a tran-
scriptional activator and an RNA-processing factor to produce
transcription and splicing effects in our assays. p54nrb acti-
vated the transcription of only the MMTV promoter (ca. four-
fold [Fig. 2A]) and slightly increased exon inclusion from all
three promoters driving the CD44 minigene (Fig. 2B). Conse-
quently, CoAA, hnRNP A1, and p54nrb represent three pro-
teins with similar architecture (Fig. 3A; also see Introduction)
that in our assays alter either both transcription and splicing or
only splicing. All the proteins or mutants tested in this work
(see below) were cloned into the same pcDNA3 expression
vector having a myc epitope coding sequence at the 3 end,
allowing Western blot-based analysis of the expression levels of
the different proteins (see Materials and Methods). Although
CoAA was expressed less than hnRNP A1 or p54nrb, this
observation did not alter our conclusions, since we compared
the effects only of one protein on different promoters; different
proteins were compared based on their respective promoter
preferential effects. Since hnRNP A1 had more effect on the
CMV-CD44 minigene than on the MMTV-CD44 minigene
and CoAA had more effect on the MMTV-CD44 minigene
than on the CMV-CD44 minigene (Fig. 2B), we concluded that
the splicing effects observed did not reflect an intrinsic ability
of the promoters to respond in a particular way to hnRNP-
related proteins.
To understand the relationship between the trancriptional
coactivation function of CoAA and its splicing activity, we next
investigated the structural mechanisms by which CoAA simi-
larly enhanced the transcriptional activity of both CMV and
PR-activated MMTV promoters but significantly affected the
splicing of CD44 products synthesized only from the PR-acti-
vated MMTV promoter.
FIG. 2. CoAA mediates promoter-preferential effects on transcription and alternative splicing. (A) MMTV-, CMV-, or HSV-luciferase
reporter genes were transfected in HeLa cells as described in Materials and Methods. The MMTV-luciferase reporter gene, transfected with PR,
was activated by Pg. The reporter genes were transfected with 300 ng of pcDNA3-CoAA (CoAA), pcDNA3-p54nrb (p54), pcDNA3-hnRNPA1
(A1), or pcDNA3 empty expression vector. The histograms represent the luciferase activity obtained in presence of either CoAA, p54nrb, or
hnRNPA1 divided by the control luciferase activity obtained in presence of the empty expression vector. The means and SD were calculated from
three separate experiments. (B) The same conditions as described for panel A were used, except that the reporter genes were MMTV-CD44,
CMV-CD44, or HSV-CD44. The histograms represent either the fold effect of CoAA and p54nrb on the skipping/inclusion ratio (open boxes) or
the fold effect of hnRNPA1 on the v4/inclusion ratio (solid boxes). The fold effect was obtained by dividing the ratio obtained in the presence of
the different protein expression vectors by the ratio obtained in the presence of the empty expression vector (ø). Means and SD were calculated
from three separate experiments. Representative autoradiograms of radioactive low-cycle RT-PCR amplification of splicing products are shown
at the bottom.
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The RRMs of CoAA mediate its transcriptional effects on a
CMV-luciferase reporter gene. On one hand, CoAA was
shown to interact with TRBP through its auxiliary domain (16),
suggesting that CoAA could be engaged in transcription
through this domain. On the other hand, the RRM motifs of
hnRNP-related proteins can bind RNAs as well as single-
stranded DNA sequences, potentially allowing the recruitment
of RRM-containing proteins to gene promoters (4, 36, 50, 55).
In consequence, theoretically, the promoter-preferential tran-
scriptional effects of CoAA could be mediated by either its
RRMs or its auxiliary domain. Experiments using deleted
CoAAs missing either the RRMs or the auxiliary domain in-
dicated that both domains were necessary for CoAA-mediated
transcriptional activity on both the CMV and the MMTV pro-
moters (data not shown). Consequently, we turned to domain
swapping between the three utilized hnRNP proteins to deter-
mine the role of each domain in mediating promoter-prefer-
ential transcriptional effects.
As shown in Fig. 3B (left), the CoAA-mediated transcrip-
tional effect on the CMV promoter was lost when the RRMs
from either hnRNPA1 (A1N-CoAAC) or p54nrb (p54N-
CoAAC) replaced the RRMs of CoAA, although the three
proteins (CoAA, A1N-CoAAC, and p54N-CoAAC) had sim-
ilar expression levels (data not shown). These results indicated
the specific importance of the CoAA RRMs for transcriptional
activity on the CMV promoter. Importantly, the CoAA RRMs
conferred CMV transcriptional activation when fused to the C
terminus of p54nrb (CoAAN-p54C). Because CoAA (but not
p54nrb) was active on the CMV promoter, this result again
emphasized the importance of CoAA RRMs for transcrip-
tional activation of the CMV promoter. As a control, we ob-
served that CoAAN-p54C was not active on the HSV pro-
moter, which was not activated by either CoAA or p54nrb (Fig.
3B, right). The CoAA RRMs were not sufficient to confer
activity to any auxiliary domain since the fusion of these RRMs
to the hnRNP A1 auxiliary domain (CoAAN-A1C) produced
no transcriptional effect although this mutant had a similar
expression level to that of CoAAN-p54C (Fig. 3B, left graph,
and data not shown). Consequently, CoAA RRMs require a
transcriptionally active auxiliary domain (CoAAC or p54C ver-
FIG. 3. The RRMs of CoAA mediate transcriptional effects on CMV-luciferase reporter gene. (A) CoAA, hnRNPA1, and p54nrb contain two
N-terminal RNA RRMs and a C-terminal auxiliary domain either rich in glycine (G) and tyrosine (Y) residues (CoAA and hnRNPA1) or rich in
acidic and basic residues (A/B, p54nrb). The RRMs and the auxiliary domains of these proteins were exchanged as described in Materials and
Methods and as illustrated on the right. (B) CMV- or HSV-luciferase reporter genes were transfected in either the presence or the absence of
various protein expression vectors as indicated and under the conditions described for Fig. 2. The histograms represent the effect on luciferase
activity of the various proteins as indicated. Means and standard deviations were obtained from at least three separate experiments. (C) CMV-
luciferase and MMTV-luciferase were transfected with TRBP expression vector and different protein expression vectors as indicated. The
histograms representing the averages of three separate experiments represent the luciferase activity obtained in the presence of the various proteins
and TRBP divided by the luciferase activity obtained in the control wells transfected with TRBP alone.
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sus none or A1C) to mediate a transcriptional effect on the
CMV promoter. The effects are specific for CoAA RRMs since
the RRMs of neither hnRNPA1 nor p54nrb can replace the
CoAA RRMs.
Interestingly, it was shown that CoAA interacts with the
promoter-recruited TRBP coregulator through its auxiliary do-
main (16) and that TRBP enhanced CoAA-mediated tran-
scriptional effects on a PR-activated MMTV promoter (Fig.
1B). Together, these observations suggested that CoAA could
be engaged through its auxiliary domain interacting with
TRBP in PR-activated MMTV transcriptional regulation and
could be engaged through its RRMs in CMV transcriptional
regulation. To test this hypothesis, we reasoned that CoAA
should enhance TRBP-mediated effects on the PR-activated
MMTV promoter but not on the CMV promoter. When TRBP
was expressed, CoAA enhanced the TRBP-mediated effects on
PR-activated MMTV-luciferase by ca. 10-fold but enhanced
the TRBP-mediated effects on CMV-luciferase by only 4-fold
(Fig. 3C). This contrasted with the equal CoAA-mediated ef-
fects previously shown for the two promoters in the absence of
TRBP (Fig. 2A). Importantly, we observed that only hybrid
proteins containing the auxiliary domain of CoAA (CoAA
itself, A1N-CoAAC, or p54N-CoAAC) were able to signifi-
cantly enhance TRBP-mediated effects on the PR-activated
MMTV promoter (Fig. 3C), although the expression levels of
these proteins containing the CoAA auxiliary domain were
lower than those of the proteins that did not contain the CoAA
auxiliary domain (A1, p54, CoAAN-A1C, and CoAAN-p54C
[data not shown]). Because the RRMs of either hnRNP A1 or
p54nrb can partially replace CoAA RRMs (A1N-CoAAC and
p54N-CoAAC, respectively) to mediate the transcriptional ef-
fect on a TRBP-activated MMTV promoter, these results em-
phasized a predominant role of the CoAA auxiliary domain on
this promoter. In contrast, and as expected, none of these
proteins enhanced the TRBP-mediated effect on the CMV
promoter (Fig. 3C).
In summary, our results suggest that CoAA is engaged in
regulating steroid-dependent MMTV transcriptional activity
through its auxiliary domain and in regulating the steroid-
independent CMV transcriptional activity through its RRMs.
To compare the transcriptional coactivation activity of CoAA
with its splicing activity, the same mutants and hybrid proteins
were used next in the splicing assay.
The RRMs of CoAA prevent splicing effects on CMV-CD44
gene products. As shown in Fig. 2, CoAA and hnRNP A1
affected CD44 splicing in different ways. CoAA significantly
promoted the skipping of both alternative exons, but did so
only when transcription occurred from the PR-activated
MMTV promoter. In contrast, hnRNP A1 promoted the skip-
ping of only exon v5 of CD44 products synthesized from either
the MMTV, CMV, or HSV promoters. Figure 4 compares the
ability of natural, deleted, and hybrid proteins to promote the
skipping of both exons (skipping/inclusion ratio) and skipping
of just exon v5 (v4/inclusion).
FIG. 4. The RRMs of CoAA prevent splicing effects on CMV-CD44 products. MMTV-CD44 (A) or CMV-CD44 (B) reporter genes were
transfected, as described in Materials and Methods, with or without the protein expression vectors as indicated. The histograms represent the fold
effect of the different proteins on either the skipping/inclusion ratio or the v4/inclusion ratio. The fold effect was obtained by dividing the ratio
obtained in the presence of the various protein expression vectors by the ratio obtained in the presence of the empty expression vector (Ø). Means
and standard deviations were calculated from three separate experiments. Representative autoradiograms of radioactive low-cycle RT-PCR
amplification of splicing products are shown on the right.
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Subdomains of CoAA or hnRNP A1 consisting of either the
RRMs or the auxiliary domain were unable to affect splicing
decisions (CoAAN, CoAAC, A1N, or A1C [Fig. 4]). Interest-
ingly, addition of the CoAA RRMs to the hnRNP A1 auxiliary
domain produced a protein (CoAAN-A1C) able to exert the
full activities of both proteins on MMTV directed pre-mRNAs
(Fig. 4A). Since both proteins (CoAA and hnRNP A1) can
affect the splicing of CD44 products synthesized from the
MMTV promoter, no conclusion can be drawn regarding the
domain requirement for their splicing activity on this particular
promoter.
In contrast, as observed using CoAA, the hybrid protein
CoAAN-A1C did not alter splicing decisions on CMV-tran-
scribed CD44 pre-mRNAs even though the expression level of
this hybrid protein was higher than that of CoAA (Fig. 4B and
data not shown). These results clearly indicate that CoAA
RRMs were responsible for the lack of CoAA effects on the
splicing of CMV-CD44 gene products (Fig. 2B and 4B).
In conclusion, CoAA RRMs play a major role in mediating
a positive transcriptional effect on the CMV promoter (Fig.
3B) and in preventing splicing effects on the CD44 pre-mRNAs
transcribed from this promoter (Fig. 4B). These observations
raise the hypothesis that CoAA could be engaged in CMV
transcriptional regulation through its RRMs, limiting the abil-
ity of the protein to be engaged in the splicing of the CD44
pre-mRNAs synthesized from this promoter. In contrast,
CoAA could be involved in splicing regulation of CD44 pre-
mRNAs synthesized from the PR-activated MMTV promoter
because CoAA is engaged in the regulation of this promoter
through its auxiliary domains (Fig. 1, 3C, and 4A).
Since CoAA and TRBP have been implicated in steroid
receptor-mediated transcription and since CoAA did not be-
have similarly when a steroid-regulated promoter (MMTV)
was compared to a steroid-independent promoter (CMV), we
investigated the transcriptional and splicing effects of CoAA by
using other steroid-regulated promoters to test whether the
ability of CoAA to simultaneously affect transcription and
splicing decisions was dependent on an intrinsic ability of ste-
roid-dependent promoters.
CoAA-mediated effects on splicing are inversely correlated
with its transcriptional effects. Our results suggested that the
role played by CoAA RRMs in transcriptional regulation of
the non-steroid-regulated CMV promoter limited the involve-
ment of CoAA in the splicing of the CD44 pre-mRNAs tran-
scribed from this promoter. In contrast, when CoAA was en-
gaged through its auxiliary domain in transcriptional
regulation of the steroid-regulated MMTV promoter, the pro-
tein could affect splicing. To test whether other steroid-depen-
dent promoters could behave like the MMTV promoter, we
tested a PRE-TATA promoter activated by Pg and an ERE-
TATA promoter activated by estradiol through the estrogen
receptors ER and ER	. Interestingly, when CoAA mediated
a strong effect in terms of transcription, we observed a modest
effect on splicing (Fig. 5). Consequently, the splicing effects
mediated by CoAA were inversely correlated with its transcrip-
tional effects on steroid-regulated promoters. These results
again demonstrate that the effects on splicing of CoAA are not
a direct consequence of its transcriptional effects. Moreover,
the results suggest that the promoter-preferential splicing ef-
fects mediated by CoAA are not dependent simply on steroid-
regulated versus non-steroid-regulated promoters but empha-
size again that the precise manner in which CoAA is engaged
in transcriptional regulation could have consequences on the
subsequent splicing regulatory activity of CoAA.
The CMV promoter does not completely abrogate CoAA-
mediated splicing effects on CMV-transcribed RNAs. We have
shown that the inability of CoAA to alter the splicing of CD44
transcripts synthesized from the CMV promoter does not re-
flect an inherent ability of this promoter to suppress the splic-
ing activity of hnRNP proteins on CD44 RNAs (Fig. 2B).
Moreover, we observed that CoAA can affect the splicing of
transcripts synthesized from this promoter. When the PR-ac-
tivated MMTV promoter was driving the CT/CGRP minigene,
CoAA increased the CT/CGRP ratio threefold whereas
hnRNPA1 decreased it fourfold (Fig. 6A). Interestingly, the
hybrid protein CoAAN-A1C mediated similar effects to CoAA
and increased the CT/CGRP ratio ca. sevenfold, suggesting
that the CoAA RRMs oriented the splicing decision (Fig. 6A).
Importantly, and in contrast to the results obtained using the
CD44 minigene (Fig. 4), CoAA and CoAAN-A1C mediated
similar but slightly smaller splicing effects on the CT/CGRP
products synthesized from the CMV promoter than on prod-
ucts synthesized from the PR-activated MMTV promoter
(compare Fig. 6B with 6A). These results suggest that the
promoter-preferential effects on splicing mediated by CoAA
are gene specific and are also influenced by the transcribed
region of the gene. Consequently, the splicing effects mediated
by CoAA, an RRM-containing transcriptional coactivator, are
simultaneously dependent on both the nature of the promoter
and the nature of the RNA product synthesized from this
promoter.
DISCUSSION
We showed previously that activated steroid receptors can
simultaneously affect transcription and splicing decisions in a
promoter-dependent manner (2). Our present hypothesis is
that activated nuclear receptors recruit a subset of coregulators
participating in the regulation of both transcription and alter-
native splicing (2). Supporting this hypothesis, we showed that
CoAA, an hnRNP-like protein identified as a nuclear receptor
FIG. 5. CoAA-mediated splicing effects are inversely correlated
with its transcriptional effects on steroid-regulated promoters. PRE-,
ERE-, or MMTV-luciferase reporter genes or PRE-, ERE-, or
MMTV-CD44 reporter genes were transfected with 5 ng of either PR,
ER, or ER	 per well and with 300 ng of CoAA expression vector or
empty expression vector per well. The open boxes represent the fold
effect of CoAA on luciferase activity, and the solid boxes represent the
fold effect of CoAA on the CD44 skipping/inclusion ratio. Means and
SD obtained from at least three separate experiments are shown.
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coactivator, can affect splicing decisions (2, 16). In the present
work, we investigated the relationship between CoAA tran-
scriptional coactivation function and its splicing activity. Using
reporter genes driven by the steroid receptor-dependent
MMTV promoter, we showed that the transcriptional and
splicing effects mediated by CoAA were enhanced by TRBP, a
protein recruited to the MMTV promoter by interacting with
activated nuclear receptors (5, 16, 20, 23, 29, 56) (Fig. 1). These
observations suggest that the CoAA-mediated effects on both
transcription and splicing are promoter dependent. Supporting
this hypothesis, we observed that CoAA demonstrated pro-
moter-preferential effects on both transcription and splicing
(Fig. 2). Importantly, CoAA similarly enhanced both PR-acti-
vated MMTV and CMV transcriptional activities but signifi-
cantly affected the splicing of CD44 products synthesized only
from the PR-activated MMTV promoter (Fig. 2). These results
consequently demonstrate that CoAA-mediated splicing ef-
fects clearly are not just a direct consequence of its transcrip-
tional activity. This conclusion was also supported by the in-
verse correlation observed between transcriptional and splicing
effects mediated by CoAA with steroid-regulated promoters
(Fig. 5). This absence of a direct correlation between transcrip-
tional and splicing effects is consistent with our previous find-
ing that transcriptional coregulators can affect transcription
without affecting splicing and that enhancement of transcrip-
tion by different transcriptional coactivators can be associated
with opposite effects on splicing (2). In conclusion, CoAA-
mediated splicing effects are promoter dependent but are not
a direct consequence of CoAA effects on the promoter tran-
scriptional activity.
Importantly, the limited splicing effect of CoAA on the
CMV-transcribed CD44 RNAs was not due to an intrinsic
ability of the CMV promoter to inhibit the splicing activity of
hnRNP proteins. Indeed, hnRNP A1 affected the splicing of
CMV-transcribed CD44 RNAs (Fig. 2). Moreover, the CMV
promoter did not completely abrogate CoAA-mediated splic-
ing effects. Indeed, CoAA affected the splicing of CMV-tran-
scribed CT/CGRP RNAs (Fig. 6). These results are consistent
with the recent observation that the splicing activity of SR
(serine- and arginine-rich) protein family splicing factors de-
pends on both the promoter and the nature of the splicing
reporter used (6, 37, 42).
To explain these promoter-preferential actions of the SR
splicing factors, two models have been proposed. PGC-1, struc-
turally related to the SR family of splicing factors, is a tran-
scriptional coregulator recruited to target promoters by the
nuclear receptor PPAR and was shown to affect splicing de-
cisions in a promoter-dependent manner (37). It was proposed
that PGC-1, when recruited to a target promoter, moves across
the gene due to its interaction with the C-terminal domain of
RNA pol II, allowing the interaction of PGC-1 with the neo-
nascent transcript, whose splicing can be affected (37). In this
model, the splicing effect of a given regulatory protein would
depend on its promoter recruitment. A second model pro-
posed that promoter-dependent effects of SR splicing factors
depend on the RNA polymerase II elongation rate. In this
model, the nature of a promoter and the nature of the tran-
scriptional regulatory complex buildup on this promoter would
control the rate at which the RNA pol II is synthesizing the
pre-mRNA. Depending on the elongation rate, SR splicing
FIG. 6. The CMV promoter does not completely abrogate CoAA-mediated splicing effects on CMV-transcribed RNA. MMTV-CT/CGRP
(A) or CMV-CT/CGRP (B) reporter genes were transfected, as described in Materials and Methods, with or without different protein expression
vectors as indicated. The histograms represent the fold effect of the various proteins on the CT/CGRP ratio. The fold effect was obtained by
dividing the ratio obtained in the presence of the various protein expression vectors by the ratio obtained in the presence of the empty expression
vector (Ø). Means and standard deviations were calculated from three separate experiments. Representative autoradiograms of radioactive
low-cycle RT-PCR amplification of splicing products are shown on the right.
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factors would have more or less time to recognize splicing-
regulatory RNA sequences. At a low elongation rate, SR splic-
ing factors would have more time to interact with their RNA
substrate than at a high elongation rate, allowing their engage-
ment in the splicing process (17, 39, 42). Consequently, in this
model, the action of a given splicing factor would depend on
the speed at which the pre-mRNA is synthesized and, very
importantly, on the affinity of the splicing factor for its target
pre-mRNA (17, 39, 42).
According to these models and based on the results pre-
sented here, we propose that promoter-specific splicing effects
mediated by a subset of hnRNP-related transcriptional/splicing
regulators could depend on the “competitive” recruitment of
these proteins by (i) the promoter and (ii) the gene product
synthesized from this promoter (Fig. 7). Indeed, we observed
that the CoAA RRMs play a major role in mediating a positive
effect on CMV transcriptional activity and in preventing the
splicing effect on CMV-transcribed CD44 RNAs (Fig. 3B and
4B). Inversely, the CoAA auxiliary domain is important in
mediating transcriptional CoAA effects on the PR-activated
MMTV promoter that also permits CoAA-mediated splicing
effects on the CD44 RNAs (Fig. 3C and 4A). This suggested
that the way in which CoAA is engaged in the transcriptional
process could affect its involvement in downstream events such
as splicing. However, importantly, the engagement of CoAA in
the splicing process is not totally dependent on the promoter.
Like the CoAA-mediated effect on CD44 RNA splicing, the
CoAA-mediated effect on CT/CGRP RNA is enhanced by
TRBP when a PR-activated MMTV promoter drives the mini-
genes (Fig. 1). However, unlike the splicing of CMV-tran-
scribed CD44 RNA, the splicing of CMV-transcribed CT/
CGRP RNA is affected by CoAA (Fig. 6). Consequently, the
engagement of CoAA in the splicing process could depend on
its engagement in transcriptional complexes and probably also
on the ability of the transcript to recruit CoAA from these
transcriptional complexes.
In the natural context of a promoter driving the synthesis of
a unique transcript, several mechanisms could coexist to mod-
ulate this “competitive” recruitment, either by modulating the
“strength” of the engagement of a given splicing regulator in
transcriptional complexes or by changing the affinity of the
regulator for the RNA transcript. For instance, it is known that
transcriptional coregulators are simultaneously engaged in sev-
eral protein-protein interactions within promoter transcrip-
tional complexes (1, 13, 35). The nature and/or number of
interactions, in which a transcriptional/splicing regulator is en-
gaged on a given promoter, could modify the local availability
of this regulator for the splicing process. Such interactions
might depend either on the nature of the transcriptional stim-
uli leading to the recruitment of various sets of coregulators or
on signaling pathways that are known to affect transcriptional
coregulator activities and that could modulate protein-protein
interactions (13, 35). Such mechanisms could modify the
“strength” at which a regulatory protein is involved in a given
transcriptional complex.
Inversely, several mechanisms could also exist to modulate
the affinity of these proteins for the RNA transcripts. It is
known that transcriptional factors recruit various transcrip-
tional coregulators harboring a variety of enzymatic activities
such as acetylation, methylation, ubiquitination, or phosphor-
FIG. 7. Competitive recruitment of RNA-binding proteins by the promoter and the transcript. A transcriptional/splicing regulator, like CoAA
could be recruited to target promoters through either DNA-protein or protein-protein interactions. Depending on the affinity of the regulator for
the transcriptional complex and for the transcript synthesized from this promoter, the regulator will or will not be able to interact with the
transcript, participating or not participating in the splicing regulation process. For instance, the engagement of CoAA through its RRMs in the
CMV promoter regulation (“Non-permissive interaction”) could restrain the ability of CoAA to be engaged in splicing (promoter A), whereas the
engagement of CoAA through its auxiliary domain in the PR-activated MMTV promoter regulation (“Permissive interaction”) could allow this
engagement (promoter B). In the natural context of a promoter driving the synthesis of an unique transcript, several mechanisms could coexist to
modulate this competition either by changing the “strength” of the engagement of a given regulator in the transcriptional complex or by changing
the affinity of the regulator for the RNA transcript (see Discussion).
VOL. 24, 2004 TRANSCRIPTIONAL AND SPLICING REGULATION BY CoAA 451
 o
n
 O
ctober 26, 2015 by University of Queensland Library
http://m
cb.asm
.org/
D
ow
nloaded from
 
ylation (13, 35). Interestingly, two RNA-binding proteins were
recently identified as substrates for the transcriptional coregu-
lator CARM1, which contains a methyltransferase activity (22,
24). Methylation of RNA-binding proteins is known to affect
their activity, notably their interaction with RNAs (18, 19, 46).
Several reports also suggest that the binding activity of RNA-
binding proteins can be affected by phosphorylation (25, 41).
p54nrb can bind either RNA or DNA depending on its phos-
phorylation status (3, 55). It also was shown that phosphory-
lation of the IQ domain of the RNA-binding protein EWS,
involved in both transcription and splicing regulation, inhibited
its interaction with RNA (8). Interestingly, CoAA contains a
similar IQ domain (data not shown). Based on these observa-
tions, an interesting possibility would be that coregulators har-
boring enzymatic activities could be recruited to target pro-
moters and could locally affect the fate of RNA-binding
proteins, in particular their ability to regulate the RNA-splic-
ing process, by modulating their ability to bind the transcripts.
In conclusion, we propose that activated nuclear receptors
recruit a subset of transcriptional coregulators and that their
ability to participate in downstream process (including alter-
native splicing decisions) is influenced by other promoter-re-
cruited coregulators, thereby permitting the promoter to con-
trol pre-mRNA-processing events in response to
transcriptional stimuli like steroid hormones. Competitive re-
cruitment of RNA-binding proteins by complexes built up on
the promoter and complexes built up on the transcripts might
have importance beyond splicing regulation. The number of
proteins identified harboring RNA-binding domains involved
in transcription is increasing rapidly (2, 21, 47, 53). Some of
these proteins act as transcription factors and bind to DNA,
and others act as transcriptional coregulators and are recruited
to target promoters by transcription factors through protein-
protein interactions (2, 21, 47, 53). Some of these RNA-bind-
ing proteins might act as feedback “sensors” of the amount of
gene products synthesized. If coregulator proteins required for
the transcriptional activity of a promoter are able also to in-
teract with the gene products synthesized from that promoter,
then when more gene products are synthesized, less RNA-
interacting protein would be available to coactivate the pro-
moter transcriptional machinery. Such a scenario would lead to
a decrease in the promoter activity until the RNA gene prod-
ucts are metabolized, translated, or degraded.
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